SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001641489-24-000061
Filing Date
2024-08-08
Accepted
2024-08-08 16:20:11
Documents
64
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vtvt-20240630.htm   iXBRL 10-Q 931343
2 EX-31.1 vtvt-20240630xexx311.htm EX-31.1 10142
3 EX-31.2 vtvt-20240630xexx312.htm EX-31.2 10361
4 EX-32.1 vtvt-20240630xexx321.htm EX-32.1 4945
5 EX-32.2 vtvt-20240630xexx322.htm EX-32.2 4918
11 GRAHPIC vtvt-20240630_g1.jpg GRAPHIC 1061794
  Complete submission text file 0001641489-24-000061.txt   8041473

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20240630.xsd EX-101.SCH 41959
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vtvt-20240630_cal.xml EX-101.CAL 47265
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vtvt-20240630_def.xml EX-101.DEF 279232
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20240630_lab.xml EX-101.LAB 560195
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20240630_pre.xml EX-101.PRE 401898
67 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20240630_htm.xml XML 633352
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37524 | Film No.: 241188712
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)